-
公开(公告)号:US20080242641A1
公开(公告)日:2008-10-02
申请号:US11695528
申请日:2007-04-02
申请人: Mitchell Wortzman , R. Todd Plott , Kuljit Bhatia , Bhiku Patel
发明人: Mitchell Wortzman , R. Todd Plott , Kuljit Bhatia , Bhiku Patel
CPC分类号: A61K31/65 , A61K9/2054 , A61K9/2077
摘要: Minocycline oral dosage forms containing a controlled release carrier are useful for the treatment of acne.
-
公开(公告)号:US20080241241A1
公开(公告)日:2008-10-02
申请号:US11695513
申请日:2007-04-02
申请人: Mitchell Wortzman , R. Todd Plott , Kuljit Bhatia , Bhiku Patel
发明人: Mitchell Wortzman , R. Todd Plott , Kuljit Bhatia , Bhiku Patel
CPC分类号: A61K31/65 , A61K9/2018 , A61K9/2054
摘要: Minocycline oral dosage forms containing a controlled release carrier are useful for the treatment of acne.
-
公开(公告)号:US20080241235A1
公开(公告)日:2008-10-02
申请号:US11695514
申请日:2007-04-02
申请人: Mitchell Wortzman , R. Todd Plott , Kuljit Bhatia
发明人: Mitchell Wortzman , R. Todd Plott , Kuljit Bhatia
CPC分类号: A61K9/2054 , A61K31/65 , A61K47/38
摘要: Minocycline oral dosage forms containing a controlled release carrier are useful for the treatment of acne.
-
公开(公告)号:US20080241197A1
公开(公告)日:2008-10-02
申请号:US11747866
申请日:2007-05-11
申请人: Mitchell Wortzman , R. Todd Plott , Kuljit Bhatia
发明人: Mitchell Wortzman , R. Todd Plott , Kuljit Bhatia
CPC分类号: A61K31/65 , A61K9/2054
摘要: Minocycline oral dosage forms containing a controlled release carrier are useful for the treatment of acne.
摘要翻译: 含有控释载体的米诺环素口服剂型可用于治疗痤疮。
-
公开(公告)号:US20080182827A2
公开(公告)日:2008-07-31
申请号:US11944186
申请日:2007-11-21
申请人: Mitchell Wortzman , R. Plott , Kuljit Bhatia , Bhiku Patel
发明人: Mitchell Wortzman , R. Plott , Kuljit Bhatia , Bhiku Patel
CPC分类号: A61K31/65
摘要: A method for treatment of acne with tetracyclines is provided. A lower sustained dose and no loading dose is employed, with an optional once-a-day dosing regimen.
-
公开(公告)号:US20080182826A2
公开(公告)日:2008-07-31
申请号:US11776676
申请日:2007-07-12
申请人: Mitchell Wortzman , R. Plott , Kuljit Bhatia , Bhiku Patel
发明人: Mitchell Wortzman , R. Plott , Kuljit Bhatia , Bhiku Patel
CPC分类号: A61K31/65
摘要: A method for treatment of acne with tetracyclines is provided. A lower sustained dose and no loading dose is employed, with an optional once-a-day dosing regimen.
-
公开(公告)号:US20080070872A1
公开(公告)日:2008-03-20
申请号:US11944186
申请日:2007-11-21
申请人: Mitchell Wortzman , R. Plott , Kuljit Bhatia , Bhiku Patel
发明人: Mitchell Wortzman , R. Plott , Kuljit Bhatia , Bhiku Patel
CPC分类号: A61K31/65
摘要: A method for treatment of acne with tetracyclines is provided. A lower sustained dose and no loading dose is employed, with an optional once-a-day dosing regimen.
-
公开(公告)号:US20080182825A2
公开(公告)日:2008-07-31
申请号:US11776669
申请日:2007-07-12
申请人: Mitchell Wortzman , R. Plott , Kuljit Bhatia , Bhiku Patel
发明人: Mitchell Wortzman , R. Plott , Kuljit Bhatia , Bhiku Patel
CPC分类号: A61K31/65
摘要: A method for treatment of acne with tetracyclines is provided. A lower sustained dose and no loading dose is employed, with an optional once-a-day dosing regimen.
摘要翻译: 提供了一种用四环素治疗痤疮的方法。 使用较低的持续剂量和无负荷剂量,可选择每天一次给药方案。
-
公开(公告)号:US20080181945A2
公开(公告)日:2008-07-31
申请号:US11776711
申请日:2007-07-12
申请人: Mitchell Wortzman , R. Plott , Kuljit Bhatia , Bhiku Patel
发明人: Mitchell Wortzman , R. Plott , Kuljit Bhatia , Bhiku Patel
CPC分类号: A61K31/65
摘要: A method for treatment of acne with tetracyclines is provided. A lower sustained dose and no loading dose is employed, with an optional once-a-day dosing regimen.
-
公开(公告)号:US20050232978A1
公开(公告)日:2005-10-20
申请号:US11153002
申请日:2005-06-14
申请人: Bhiku Patel , Mohan Vishnupad , Eugene Gans , Kuljit Bhatia
发明人: Bhiku Patel , Mohan Vishnupad , Eugene Gans , Kuljit Bhatia
IPC分类号: A01N25/34 , A61F13/00 , A61J20060101 , A61K9/22 , A61K9/70 , A61K31/192 , A61K31/327 , A61K31/63 , A61L15/16
CPC分类号: A61K9/0014 , A61K31/327 , A61M35/006
摘要: The present invention is a delivery system comprising a pad and a liquid composition, comprising an insoluble dermatologically active ingredient with a viscosity that permits substantially uniform absorption of the composition onto the pad, and the pad is in then packaged in a sealed container.
-
-
-
-
-
-
-
-
-